Graphical Abstract Graphical Abstract Mechanism of action of available IL-1 agents for pericarditis: (1) anakinra (Anak) is a recombinant IL-1 receptor antagonist blocking either IL-1α or IL-1β; (2) rilonacept is a fusion protein forming a trap that binds IL-1α or IL-1β and IL1Ra; (3) canakinumab is an IgG1 human monoclonal antibody targeted at IL-1β.
All Keywords
【저자키워드】 Anakinra, interleukin-1, Pericarditis, rilonacept,
【저자키워드】 Anakinra, interleukin-1, Pericarditis, rilonacept,